Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amgen, Cytodyn, Daewoong, Five Prime, Flexion, Kadmon, Lundbeck, Millendo, Protagonist, Revance, Savara, Scholar Rock.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aldeyra, Arca, Atara, Avrobio, Bicycle, Calcimedica, Cidara, Eli Lilly, Enanta, Enlivex, Hightide, Innovent, Ironwood, Monopar, Ovid, Oxurion, Progenics, Rising, Rubius, Sobi, Solid, Theravance, Wize, X4.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Alnylam, Amgen, Axcella, Eisai, Ferring, Galecto, Humanigen, Jounce, Lilly, Lineage Cell, Merck and Co., Mesoblast, Noxopharm, Nucana, Oncosec, Rebiotix, Rigel, Scholar Rock, Spero, Teva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aduro, Adverum, Akebia, Angion, Athersys, Baudax, Bicycle, Biontech, Corcept, Delmar, Nabriva, Pfizer, Redhill, Regeneron, Sanofi, TG Therapeutics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Akari, Astrazeneca, Athersys, Azurrx, BMS, Calcimedica, Eiger, Flexion, Ipsen, Kubota, Lilly, Merck, Novartis, Synairgen, TG.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Bellus, Gilead, GSK, Janssen, Jazz, Leo, Lilly, Mallinckrodt, Mesoblast, Morphosys, Novartis, Palatin, Sanofi, Silence, Soligenix, Spectrum, Urogen, Vertex, Yuhan.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biontech, Cadent, Chimerix, Corbus, Destiny, Dynavax, Erytech, Geneone, Gilead, Gracell, Inovio, Pfizer, United Therapeutics, Windtree.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apellis, Bioxcel, Blueprint, Genentech, Generex, I-Mab, Innate, Innovent, Inovio, Morphosys, Ocular, Orchard, R-Pharm, Rafael, Spectrum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Avadel, Axsome, CTI Biopharma, Harpoon, Hua, Italfarmaco, Myovant, Regeneron, Sanofi, Valo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bellicum, Boehringer, Chugai, GSK, Janssen, Kiromic, Merck, Novartis, Novocure, Noxxon, Sanofi, TC Biopharma, Tonix, UCB.